News | Proton Therapy | December 17, 2015

St. Jude Children's Research Hospital Opens New Proton Therapy Center

First proton center fully dedicated to pediatric cancer will feature Hitachi system with spot scanning irradiation technology

Hitachi, St. Jude Children's Research Hospital, Red Frog Events Proton Therapy Center

December 17, 2015 — Hitachi Ltd. announced that St. Jude Children’s Research Hospital opened the St. Jude Red Frog Events Proton Therapy Center in Memphis, Tennessee, the world’s first proton therapy center solely dedicated to children. The new center has 190-degree half gantries that provide efficient and spacious treatment-room environments suited specifically for pediatric care. All rooms are equipped with spot-scanning irradiation, a technology for which Hitachi received the first U.S. Food and Drug Administration (FDA) Premarket Notification Special 510(k) clearance in 2007.

St. Jude will be Hitachi’s third proton therapy site in the United States.

“The opening of the St. Jude Red Frog Events Proton Therapy Center marks an important step in our efforts to provide therapies that maximize cures while minimizing long-term treatment complications,” said James R. Downing, M.D., St. Jude president and chief executive officer. “The center is an engineering marvel made possible through the talents of many who are committed to offering children with cancer the best hope for the future.”

Radiation therapy, used alone or in combination with surgery and chemotherapy, is an integral component for successfully managing and treating pediatric tumors. Proton therapy allows doctors to administer targeted, high-dose radiation while sparing surrounding healthy tissue from exposure.

Proton beam therapy is an advanced form of external beam radiotherapy in which the protons from a hydrogen atom are extracted and accelerated up to 70 percent the speed of light. The energy beam is concentrated directly on the tumor, minimizing radiation doses to the surrounding healthy tissues. The procedure has fewer side effects compared to traditional radiotherapy.

Spot-scanning irradiation technology does not scatter proton beams like conventional proton beam therapy does. Rather, it repeatedly turns a narrow proton beam on and off at high speed as it progressively changes location to irradiate entire tumor volumes. Protons can be aimed with high precision at targeted tumors, even those with complex shapes, while minimizing the impact on nearby healthy tissue.

For more information: www.hitachi.com

Related Content

News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
Mercy Signs Multi-System, Multi-Hospital Agreement for Accuray Radiotherapy Systems
News | Radiation Therapy | May 16, 2018
Accuray Inc. signed a multi-system, multi-hospital agreement with Mercy for the acquisition of Accuray Radixact and...
ViewRay Unveils New Soft Tissue Visualization Technologies for MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | April 30, 2018
ViewRay Inc. announced new magnetic resonance imaging (MRI) technologies under development for its MRIdian Linac...
MedStar Georgetown Conducts World's First Hyperscan Proton Therapy Treatment
News | Proton Therapy | April 27, 2018
For the first time, cancer patients in the Washington, D.C. metropolitan region have access to proton therapy, now...
Designed to support a broad range of planning and delivery technologies, SunCheck 2.0 streamlines and standardizes workflows, allowing greater overall focus on patient safety.
Technology | Quality Assurance (QA) | April 27, 2018
Sun Nuclear Corp. released significant new functionality for its SunCheck Platform for patient and machine quality...
RayStation Users Win Inaugural Treatment Planning World Championships
News | Treatment Planning | April 27, 2018
In the first World Championships of Treatment Planning, arranged by radiation oncology analytics company ProKnow and...
Brainlab Introduces New Hi-Res Planning Algorithm for VersaHD
News | Treatment Planning | April 24, 2018
Brainlab announced the implementation of a software solution that can achieve better radiation dose conformity around...
Shorter Radiotherapy Courses Safe and Effective for Prostate Cancer
News | Prostate Cancer | April 23, 2018
Radiotherapy given in high doses over a shorter period of time is safe and effective for prostate cancer patients,...
Elekta Expands Mosaiq Oncology Information System With PalabraApps
News | Oncology Information Management Systems (OIMS) | April 20, 2018
April 20, 2018 — Elekta announced that it is making a strategic investment in PalabraApps LLC to advance the developm
This image, taken with Canon's Aquilion One, shows a lung with metastases from bowel cancer.

This image, taken with Canon’s Aquilion One, shows a lung with metastases from bowel cancer. Image courtesy of Canon.

Feature | Lung Cancer | April 18, 2018 | Jeff Zagoudis
In recent years, low-dose computed tomography (CT) screening has emerged as a proven, effective method to detect lung
Overlay Init